Home » Analyst Articles – US

D. Boral Capital Reiterates Buy Rating for Veritone (NASDAQ:VERI)

D. Boral Capital Reiterates Buy Rating for Veritone (NASDAQ:VERI)

Veritone (NASDAQ:VERI – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at D. Boral Capital in a report released on Tuesday,Benzinga reports. They currently have a $23.00 target price... More of this article »
Wells Fargo & Company Issues Pessimistic Forecast for Visteon (NASDAQ:VC) Stock Price

Wells Fargo & Company Issues Pessimistic Forecast for Visteon (NASDAQ:VC) Stock Price

Visteon (NASDAQ:VC – Get Free Report) had its price objective cut by equities research analysts at Wells Fargo & Company from $151.00 to $148.00 in a research report issued to clients and investors on Tuesday,Benzinga reports.... More of this article »
Argus Issues Pessimistic Forecast for T-Mobile US (NASDAQ:TMUS) Stock Price

Argus Issues Pessimistic Forecast for T-Mobile US (NASDAQ:TMUS) Stock Price

T-Mobile US (NASDAQ:TMUS – Get Free Report) had its price objective dropped by stock analysts at Argus from $275.00 to $245.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has a “buy”... More of this article »
JPMorgan Chase & Co. Begins Coverage on Vor Biopharma (NASDAQ:VOR)

JPMorgan Chase & Co. Begins Coverage on Vor Biopharma (NASDAQ:VOR)

Equities researchers at JPMorgan Chase & Co. started coverage on shares of Vor Biopharma (NASDAQ:VOR – Get Free Report) in a report issued on Tuesday, Marketbeat.com reports. The brokerage set an “overweight”... More of this article »
Sarepta Therapeutics (NASDAQ:SRPT) Coverage Initiated at Wedbush

Sarepta Therapeutics (NASDAQ:SRPT) Coverage Initiated at Wedbush

Research analysts at Wedbush assumed coverage on shares of Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) in a research note issued to investors on Tuesday, MarketBeat Ratings reports. The brokerage set an “outperform”... More of this article »
Senti Biosciences (NASDAQ:SNTI) Stock Price Expected to Rise, Chardan Capital Analyst Says

Senti Biosciences (NASDAQ:SNTI) Stock Price Expected to Rise, Chardan Capital Analyst Says

Senti Biosciences (NASDAQ:SNTI – Get Free Report) had its price target lifted by analysts at Chardan Capital from $12.00 to $13.00 in a research note issued on Tuesday,Benzinga reports. The brokerage currently has a “buy”... More of this article »
BTIG Research Reiterates “Buy” Rating for Syndax Pharmaceuticals (NASDAQ:SNDX)

BTIG Research Reiterates “Buy” Rating for Syndax Pharmaceuticals (NASDAQ:SNDX)

Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at BTIG Research in a note issued to investors on Tuesday,Benzinga reports. They currently... More of this article »
Telsey Advisory Group Reaffirms “Outperform” Rating for ThredUp (NASDAQ:TDUP)

Telsey Advisory Group Reaffirms “Outperform” Rating for ThredUp (NASDAQ:TDUP)

ThredUp (NASDAQ:TDUP – Get Free Report)‘s stock had its “outperform” rating reissued by research analysts at Telsey Advisory Group in a research report issued on Tuesday,Benzinga reports. They presently have... More of this article »
Royal Bank Of Canada Forecasts Strong Price Appreciation for Wingstop (NASDAQ:WING) Stock

Royal Bank Of Canada Forecasts Strong Price Appreciation for Wingstop (NASDAQ:WING) Stock

Wingstop (NASDAQ:WING – Get Free Report) had its price target increased by Royal Bank Of Canada from $300.00 to $350.00 in a research note issued to investors on Tuesday, MarketBeat Ratings reports. The firm currently has an... More of this article »
SLM (NASDAQ:SLM) Rating Lowered to “Sell” at Compass Point

SLM (NASDAQ:SLM) Rating Lowered to “Sell” at Compass Point

SLM (NASDAQ:SLM – Get Free Report) was downgraded by equities researchers at Compass Point from a “buy” rating to a “sell” rating in a research report issued on Tuesday, MarketBeat reports. They presently... More of this article »
Cantor Fitzgerald Increases WAVE Life Sciences (NASDAQ:WVE) Price Target to $34.00

Cantor Fitzgerald Increases WAVE Life Sciences (NASDAQ:WVE) Price Target to $34.00

WAVE Life Sciences (NASDAQ:WVE – Get Free Report) had its price target boosted by stock analysts at Cantor Fitzgerald from $12.00 to $34.00 in a report issued on Tuesday, Marketbeat Ratings reports. The firm presently has an... More of this article »
Synopsys (NASDAQ:SNPS) Stock Rating Upgraded by Rosenblatt Securities

Synopsys (NASDAQ:SNPS) Stock Rating Upgraded by Rosenblatt Securities

Synopsys (NASDAQ:SNPS – Get Free Report) was upgraded by investment analysts at Rosenblatt Securities from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, MarketBeat Ratings... More of this article »
FY2029 EPS Forecast for Dyne Therapeutics Raised by Analyst

FY2029 EPS Forecast for Dyne Therapeutics Raised by Analyst

Dyne Therapeutics, Inc. (NASDAQ:DYN – Free Report) – Stock analysts at HC Wainwright raised their FY2029 earnings per share estimates for Dyne Therapeutics in a report released on Monday, December 8th. HC Wainwright analyst... More of this article »
Q4 Earnings Forecast for Murphy USA Issued By Zacks Research

Q4 Earnings Forecast for Murphy USA Issued By Zacks Research

Murphy USA Inc. (NYSE:MUSA – Free Report) – Stock analysts at Zacks Research dropped their Q4 2025 earnings estimates for shares of Murphy USA in a research note issued on Monday, December 8th. Zacks Research analyst Team... More of this article »
Equities Analysts Issue Forecasts for DTI Q4 Earnings

Equities Analysts Issue Forecasts for DTI Q4 Earnings

Drilling Tools International Corp. (NASDAQ:DTI – Free Report) – Sidoti Csr upped their Q4 2025 earnings per share (EPS) estimates for Drilling Tools International in a note issued to investors on Monday, December 8th.... More of this article »
What is KeyCorp’s Forecast for TMO Q4 Earnings?

What is KeyCorp’s Forecast for TMO Q4 Earnings?

Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) – Equities researchers at KeyCorp issued their Q4 2025 EPS estimates for shares of Thermo Fisher Scientific in a research note issued on Sunday, December 7th. KeyCorp... More of this article »
Zacks Research Issues Optimistic Forecast for IBKR Earnings

Zacks Research Issues Optimistic Forecast for IBKR Earnings

Interactive Brokers Group, Inc. (NASDAQ:IBKR – Free Report) – Zacks Research raised their FY2025 earnings per share (EPS) estimates for shares of Interactive Brokers Group in a research report issued to clients and investors... More of this article »
Micron Technology (NASDAQ:MU) Stock Price Expected to Rise, Susquehanna Analyst Says

Micron Technology (NASDAQ:MU) Stock Price Expected to Rise, Susquehanna Analyst Says

Micron Technology (NASDAQ:MU – Get Free Report) had its target price increased by equities researchers at Susquehanna from $200.00 to $300.00 in a research report issued to clients and investors on Monday,Benzinga reports. The... More of this article »
Citigroup Lowers Snowflake (NYSE:SNOW) Price Target to $300.00

Citigroup Lowers Snowflake (NYSE:SNOW) Price Target to $300.00

Snowflake (NYSE:SNOW – Get Free Report) had its price target cut by research analysts at Citigroup from $310.00 to $300.00 in a report released on Monday,Benzinga reports. The brokerage currently has a “buy” rating... More of this article »
Johnson Rice Reiterates Hold Rating for Fluence Energy (NASDAQ:FLNC)

Johnson Rice Reiterates Hold Rating for Fluence Energy (NASDAQ:FLNC)

Fluence Energy (NASDAQ:FLNC – Get Free Report)‘s stock had its “hold” rating reaffirmed by equities researchers at Johnson Rice in a note issued to investors on Monday, MarketBeat.com reports. They presently... More of this article »
CVS Health (NYSE:CVS) Stock Price Expected to Rise, Wolfe Research Analyst Says

CVS Health (NYSE:CVS) Stock Price Expected to Rise, Wolfe Research Analyst Says

CVS Health (NYSE:CVS – Get Free Report) had its price target boosted by analysts at Wolfe Research from $85.00 to $100.00 in a research note issued on Monday,MarketScreener reports. The firm currently has an “outperform”... More of this article »
Netflix (NASDAQ:NFLX) Earns Buy Rating from UBS Group

Netflix (NASDAQ:NFLX) Earns Buy Rating from UBS Group

Netflix (NASDAQ:NFLX – Get Free Report)‘s stock had its “buy” rating reissued by analysts at UBS Group in a note issued to investors on Monday,MarketScreener Latest Ratings reports. They presently have a $150.00... More of this article »
Truist Financial Boosts Praxis Precision Medicines (NASDAQ:PRAX) Price Target to $500.00

Truist Financial Boosts Praxis Precision Medicines (NASDAQ:PRAX) Price Target to $500.00

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) had its price objective raised by investment analysts at Truist Financial from $360.00 to $500.00 in a research note issued on Monday, Marketbeat Ratings reports. The... More of this article »
Netflix (NASDAQ:NFLX) Earns Buy Rating from Canaccord Genuity Group

Netflix (NASDAQ:NFLX) Earns Buy Rating from Canaccord Genuity Group

Netflix (NASDAQ:NFLX – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at Canaccord Genuity Group in a research note issued to investors on Monday,Benzinga reports. They currently have a... More of this article »
TD Cowen Forecasts Strong Price Appreciation for Praxis Precision Medicines (NASDAQ:PRAX) Stock

TD Cowen Forecasts Strong Price Appreciation for Praxis Precision Medicines (NASDAQ:PRAX) Stock

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) had its price objective raised by analysts at TD Cowen from $251.00 to $353.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a “buy”... More of this article »